IMC Chicago’s Frontline FRO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.87M Sell
82,400
-32,200
-28% -$983K ﹤0.01% 2257
2025
Q4
$2.5M Buy
114,600
+60,300
+111% +$1.41M ﹤0.01% 2240
2025
Q3
$1.24M Sell
54,300
-57,400
-51% -$1.16M ﹤0.01% 2563
2025
Q2
$1.83M Buy
111,700
+79,600
+248% +$1.35M ﹤0.01% 2073
2025
Q1
$477K Buy
+32,100
New +$531K ﹤0.01% 2686
2024
Q1
Sell
-26,800
Closed -$537K 2401
2023
Q4
$537K Buy
26,800
+12,200
+84% +$252K ﹤0.01% 1617
2023
Q3
$274K Buy
+14,600
New +$246K ﹤0.01% 1541
2023
Q2
Sell
-14,400
Closed -$238K 1321
2023
Q1
$238K Sell
14,400
-24,600
-63% -$387K ﹤0.01% 1259
2022
Q4
$473K Buy
+39,000
New +$501K ﹤0.01% 1147

Other funds holding FRO

IMC Chicago's FRO Position: Q1 2026 in Review

IMC Chicago increased its Frontline (FRO) stake by 389% in Q1 2026, buying an estimated $2.79M and bringing the position to 114,698 shares worth $4M. The position accounts for ﹤0.01% of the portfolio, ranked #1981.

IMC Chicago first reported a position in FRO in Q3 2025 and has held it in 3 quarters since. 239 funds tracked by Wall St. Rank hold FRO as of Q1 2026.

  • IMC Chicago held 114,698 shares of Frontline worth $4M as of Q1 2026.
  • IMC Chicago bought 91,230 Frontline shares in Q1 2026, an estimated $2.79M.
  • Frontline made up ﹤0.01% of IMC Chicago's portfolio in Q1 2026, its #1981 holding.
  • IMC Chicago first reported a position in Frontline in Q3 2025 and has held it in 3 quarters since.
  • 239 funds tracked by Wall St. Rank held Frontline as of Q1 2026.

Based on IMC Chicago's 13F filing for Q1 2026, filed 5 May 2026.